Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
san francisco blog main
4
×
vc
4
×
deals
gene therapy
new york blog main
san francisco top stories
startups
biotech
boston
car-t
crispr
gene editing
hemophilia
illumina
national
new york top stories
san diego blog main
san diego top stories
venture capital
adeno-associated virus
administration
alexandria venture investments
alnylam pharmaceuticals
altitude life science ventures
alzheimer's
american society of gene and cell therapy
amgen
amy schulman
andreas klein
anna greka
arch venture partners
barry greene
bellicum pharmaceuticals
biogen
biomarin pharmaceutical
What
gene
4
×
therapy
bio
cutting
edge
medicines
science
aren’t
becker
billions
car
create
crispr
crude
despite
diagnostic
diseases
dollars
eaton
editing
effects
encoded
experiments
fix
healthcare
heats
help
high
hot
human
illumina’s
impact
interference
lasting
launch
launches
life
limited
limits
long
Language
Current search:
vc
×
" san francisco blog main "
×
gene
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”